- Home
- NRDS vs BLFS Comparison
NRDS vs BLFS Comparison
Compare NRDS & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRDS | BLFS |
|---|---|---|
| Founded | 2009 | 1987 |
| Country | US | |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.2B |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRDS | BLFS |
|---|---|---|
| Price | $10.13 | $22.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $15.83 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 927.9K | 326.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 353.33 | N/A |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $687,600,000.00 | N/A |
| Revenue This Year | $22.09 | $18.45 |
| Revenue Next Year | $7.18 | $16.27 |
| P/E Ratio | $10.87 | ★ N/A |
| Revenue Growth | ★ 14.71 | N/A |
| 52 Week Low | $7.55 | $19.15 |
| 52 Week High | $16.24 | $29.57 |
Technical Indicators
Market Signals| Indicator | NRDS | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 35.15 | 46.69 |
| Support Level | $9.07 | $21.71 |
| Resistance Level | $12.64 | $22.99 |
| Average True Range (ATR) | 0.63 | 1.03 |
| MACD | -0.09 | 0.04 |
| Stochastic Oscillator | 28.67 | 69.61 |
Price Performance
Historical ComparisonAbout NRDS NerdWallet Inc.
Nerdwallet Inc is a company that provides consumer-driven advice about personal finance through its platform by connecting individuals and small and mid-sized businesses (SMBs) with providers of financial products. It gets revenue from fees paid by its financial services partners in the form of either revenue per action, revenue per click, revenue per lead and revenue per funded loan arrangements.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.